Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Vijaypd Ceutical IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 19.25 Cr
Profile
Price Range 35  to  35 per share
Profile
Min Investment ₹35
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are engaged in the business of distributor and supplier of the pharmaceutical products and consumer goods sectors,offering a comprehensive range of services. Our roles include being representatives, dealers, agents, stockists, suppliers,traders, and packers. We provide a wide range of products, serving both the pharmaceutical and wellness industries, as wellas the fast moving consumer goods (FMCG) market, including pharmaceutical and wellness products such as medicines,including injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral products; vitamins,hormones, enzymes, and wellness tonics; serums and diagnostic test kits, and fast-moving consumer goods, such as personalcare and toiletries like soaps, sanitizers, and baby care items; ayurvedic product; cosmetics and food products andadditionally, we provide dental products, crude drugs. Read More

Basic Info

Face Value 10 per share

Price 35  to  35 per share

P/E (x) 9.2

Sales( Cr.) 107

PAT( Cr.) 5

EPS 3.8

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Samit Madhukar Shah Bhavin Dhirendra Shah Narendra Nagindas Shah Dina Madhukar Shah Vasanti Dhirendra Shah Rahul Jitendra Shah Hemanti Jitendra Shah

Pre Issue Share Holding 78.3%

Post Issue Share Holding 56.25%

Listing Details:

Listing Price: 35

Listing Gain: 0%

Current Price: 99.5

Gain On Issue: 99.5 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Sep 29, 2025
Closing Date Oct 01, 2025
Allotment Oct 02, 2025
Refund Oct 03, 2025
Delivery of Shares Oct 03, 2025
Listing Date Oct 06, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 8000 280,000
Retail (Max) -- -- --
S-HNI (Min) 1 8000 280,000
S-HNI (Max) 3 24000 840,000
B-HNI (Min) 4 32000 1,120,000

Objective of the Issue

1. Funding of capital expenditure requirements of our company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra 2. Repayment/prepayment of all or certain of our borrowings availed of by our Company 3. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 0 5128000 0x
Retail 0 2320000 0x
EMP 0 0 0x
Total 0 7448000 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Vijaypd Ceutical Profit & Loss

#(Fig in Cr.) Mar 2025 TTM
Net Sales 107
Other Income 1
Total Income 108
Total Expenditure 98
Operating Profit 9
Interest 2
Depreciation 1
Exceptional Income / Expenses 0
Profit Before Tax 7
Provision for Tax 2
Profit After Tax 5
Adjustments 0
Profit After Adjustments 5
Adjusted Earnings Per Share 3.4

Vijaypd Ceutical Balance Sheet

#(Fig in Cr.) Mar 2025
Shareholder's Funds 32
Minority's Interest 0
Borrowings 0
Other Non-Current Liabilities 0
Total Current Liabilities 24
Total Liabilities 57
Fixed Assets 8
Other Non-Current Assets 2
Total Current Assets 46
Total Assets 57

Vijaypd Ceutical Cash Flow

#(Fig in Cr.) Mar 2025
Opening Cash & Cash Equivalents 14
Cash Flow from Operating Activities -8
Cash Flow from Investing Activities -1
Cash Flow from Financing Activities -2
Net Cash Inflow / Outflow -11
Closing Cash & Cash Equivalent 3

Vijaypd Ceutical Ratios

# Mar 2025
Earnings Per Share (Rs) 3.42
CEPS(Rs) 3.91
DPS(Rs) 0
Book NAV/Share(Rs) 22.93
Core EBITDA Margin(%) 8.04
EBIT Margin(%) 8.12
Pre Tax Margin(%) 6.11
PAT Margin (%) 4.49
Cash Profit Margin (%) 5.14
ROA(%) 8.4
ROE(%) 14.91
ROCE(%) 16.08
Receivable days 81.32
Inventory Days 39.42
Payable days 8.63
PER(x) 0
Price/Book(x) 0
Dividend Yield(%) 0
EV/Net Sales(x) 0.31
EV/Core EBITDA(x) 3.49
Net Sales Growth(%) 0
EBIT Growth(%) 0
PAT Growth(%) 0
EPS Growth(%) 0
Debt/Equity(x) 0.68
Current Ratio(x) 1.9
Quick Ratio(x) 1.43
Interest Cover(x) 4.03
Total Debt/Mcap(x) 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 15% 15% 15% 15%
ROCE Average 16% 16% 16% 16%

Company Contact Information

Vijaypd Ceutical Ltd.

Madhuri Ganesh Batwal

+91 9820917040

investors@vijaypdceutical.com

A/1, 1st Floor Devraj Premises C H S L Goregaon (West)

IPO Lead Manager(s)

Vijaypd Ceutical Ltd.

Smart Horizon Capital Advisors Pvt Ltd.

Registrar Info

Vijaypd Ceutical Ltd.

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District, Nanakramguda Hyderabad – 500032 Tel. No. 040 67161500 Fax. No. 040 23001153 E-mail: einward.ris@karvy.com Website: www.karvy.com Toll Free No. of exclusive Call Centre:1-800-345001

040 - 67162222/18003094001

einward.ris@kfintech.com

https://www.kfintech.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp